MILAN & MORRISTOWN, N.J.–(BUSINESS WIRE)–Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused …
Read More »
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Nov. 19, 2019 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ: CRSP) …
Read More »
INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration …
Read More »
DUBLIN, Nov. 19, 2019 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that it has …
Read More »
Copenhagen, Denmark, November 19, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with …
Read More »
Pratteln, Switzerland, November 19, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces publication of the previously reported …
Read More »
BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of …
Read More »
BETHESDA, Maryland, Nov. 18, 2019 /PRNewswire-HISPANIC PR WIRE/ — Children born to women on HIV …
Read More »
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug …
Read More »
CAMBRIDGE, Ma. and ROSTOCK, Germany, Nov. 18, 2019 (GLOBE NEWSWIRE) — Centogene N.V. (NASDAQ: CNTG), …
Read More »
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage …
Read More »
GREENVILLE, S.C. & PARIS–(BUSINESS WIRE)–KIYATEC, Inc. and CarThera announce today that they have entered into a clinical collaboration …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
NEW YORK and BASEL, Switzerland, Nov. 18, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. …
Read More »
BOSTON and AUSTIN, Texas, Nov. 18, 2019 (GLOBE NEWSWIRE) — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
